Abnormal Psychology 6th Interntional Edition
Out of stock
Articulation and Phonological Disorders: Speech Sound Disorders in Children 7th International Edition
A classic in the field, Articulation and Phonological Disorders: Speech Sound Disorders in Children, 7e, presents the most up-to-date perspectives on the nature, assessment, and treatment of speech sound disorders. A must-have reference, this classic book delivers exceptional coverage of clinical literature and focuses on speech disorders of unknown causes. Offering a range of perspectives, it covers the normal aspects of speech sound articulation, normal speech sound acquisition, the classification of and factors related to the presence of phonological disorders, the assessment and remediation of speech sound disorders, and phonology as it relates to language and dialectal variations. This edition features twelve manageable chapters, including a new chapter on the classification of speech sound disorders, an expanded discussion of childhood apraxia of speech, additional coverage of evidence-based practices, and a look at both motor-based and linguistically-based treatment approaches.
About the Author
Dr. John Bernthal is professor emeritus of Special Education and Communication Sciences and Disorders at the University of Nebraska-Lincoln. He has been a speech-language pathologist for over forty years, including employment in the public schools, at several universities, and professor and department chair for over thirty years. He conducted research, taught and published in the area of speech sounds disorders. He is a past president of the American Speech Language Hearing Association, an ASHA Fellow, and recipient of Honors of the Association. Dr. Nicholas Bankson is a professor emeritus at James Madison University. He has had a forty year career as a speech-language pathologist, including employment in the public schools, serving as the state supervisor of school programs in Kansas, plus twenty-seven years as a department chair in Communication Sciences and Disorders at Boston University and James Madison University. His scholarly efforts have focused on speech sound disorders and the assessment of language disorders in children. He is an ASHA Fellow, and a recipient ASHA’s Honors of the Association award. Dr. Peter Flipsen Jr., is a professor of Speech-Language Pathology at Idaho State University. He has more than twenty years of experience in the field as a clinician, teacher, and researcher. He teaches courses in phonetics and speech sound disorders in children and has published more than twenty peer-reviewed journal articles in the field. His research has focused on the classification of speech sound disorders, measurement of intelligibility of speech, and speech and language development in children with cochlear implants.
About the Author
Daniel Kahneman is Eugene Higgins Professor of Psychology Emeritus at Princeton University and Professor of Psychology and Public Affairs Emeritus at Princeton’s Woodrow Wilson School of Public and International Affairs. He received the 2002 Nobel Prize in Economic Sciences for his pioneering work with Amos Tversky on decision-making.
New and emerging directions in pharmaceutical research to better treat schizophrenia
Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease. Moreover, many schizophrenia patients fail to respond to current antipsychotics. Integrating chemistry, biology, and pharmacology, this book explores emerging directions in pharmaceutical research for drug targeting and discovery in order to find more effective treatments for schizophrenia, one of the most serious and widespread psychiatric diseases.
Targets and Emerging Therapies for Schizophrenia presents the basics of schizophrenia, drug targets for the disease, and potential new drugs and therapeutics. It begins with a discussion of prevalence and etiology. Then, it describes therapies such as dopamine agonists and phosphodiesterase (PDE) inhibitors as well as growing research aimed at addressing untreated symptoms. Next, the authors discuss receptor modulators, inhibitors, and targeting strategies for drug discovery. Both the neurobiological and chemical aspects of all major pharmacological targets are examined.
With contributions from an international team of pioneering pharmaceutical researchers, this book compiles the current knowledge in the field, setting the stage for new breakthroughs in the treatment of schizophrenia. Targets and Emerging Therapies for Schizophrenia:
- Provides a comprehensive resource for neuro-drug discovery and the development of molecular targets for schizophrenia treatment
- Draws from chemistry, biology, and pharmacology for more effective drug targeting and discovery
- Explores a wide range of receptors and molecular targets, including dopamine, PDEs, and neuropeptides
With Targets and Emerging Therapies for Schizophrenia as their guide, drug discovery and development scientists have the information they need to advance their own research so that new, more effective treatments for schizophrenia will soon be a reality.
Culture affects us in nearly every aspect of American life, and David Matsumoto provides readers with the knowledge and skills necessary to interact in our multicultural and pluralistic world.
This field-leading book puts psychological theories and concepts into a cross-cultural framework that invites readers to discover, question, and ultimately, understand the relationship between culture and psychology through exploration of topics like changing gender roles, sexuality, self-esteem, aggression, personality, and mate selection. It all adds up to a book that will leave readers with a deeper, more complex understanding of the nature of culture, its relationship to psychological processes, and the differences and similarities between cultures in the increasingly globalized world.